Interleukin-5 — Drug Target
All drugs that target Interleukin-5 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Interleukin-5 Antagonist [EPC]
Marketed (3)
- Nucala · GSK · Interleukin-5 Antagonist [EPC] · Respiratory
Nucala works by binding to interleukin-5, a protein that stimulates the production of eosinophils. - Nucala · Mayo Clinic · Respiratory
- Cinqair · Teva Respiratory Llc · Interleukin-5 Antagonist [EPC] · Respiratory
Cinqair works by blocking the action of interleukin-5, a protein that promotes the production of eosinophils, which contribute to inflammation in the airways.